DA Wallach (L) and Ron Burkle (Photo by Jerod Harris/Getty Images for Netflix)
October 26, 2022 02:14 PM EDTUpdated October 28, 03:13 AM
Financing
Deals
Bioregnum

A one-time pop singer with mega-mon­ey star con­nec­tions hatch­es a $100M plan to in­vest in ‘con­trar­i­an’ biotech ideas

Even back in the day as the singer for Chester French, a two-man in­die pop group that spo­rad­i­cal­ly flared in­to pub­lic sight with songs like …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

Sarep­ta li­cens­es Ar­row­head­'s RNA-based rare dis­ease pipeline, promis­ing big biobucks

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

A service from the Financial Times